 | • レポートコード：MRC23Q36933 • 出版社/出版日：QYResearch / 2023年3月 • レポート形態：英文、PDF、89ページ • 納品方法：Eメール（2-3日） • 産業分類：医療機器 |
| Single User | ￥435,000 (USD2,900) | ▷ お問い合わせ |
| Enterprise License | ￥870,000 (USD5,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートは世界のコンビネーション吸入器市場について調査・分析し、世界のコンビネーション吸入器市場概要、メーカー別競争状況、地域別市場規模、タイプ別セグメント分析（加圧定量吸入器、ドライパウダー吸入器）、用途別セグメント分析（喘息、慢性閉塞性肺疾患、その他）、主要企業のプロファイル、市場動向などに関する情報を掲載しています。主要企業としては、AstraZeneca、GlaxoSmithKline、Zydus Cadila、Cipla、Maya Biotech、Boehringer Ingelheim International GmbH、Novartis AGなどが含まれています。世界のコンビネーション吸入器市場は、2022年にXXX米ドル、2029年にはXXX米ドルに達すると予測され、予測期間の年平均成長率はXXX％です。COVID-19とロシア・ウクライナ戦争の影響は、コンビネーション吸入器市場規模を推定する際に考慮しました。本レポートは、コンビネーション吸入器の世界市場を定量的・定性的な分析により包括的に提示し、読者がビジネス/成長戦略を策定し、市場競争状況を把握し、現在の市場における自社のポジションを分析し、コンビネーション吸入器に関するビジネス上の意思決定に役立てることを目的としています。 ・コンビネーション吸入器市場の概要 - 製品の定義 - コンビネーション吸入器のタイプ別セグメント - 世界のコンビネーション吸入器市場規模：タイプ別分析（加圧定量吸入器、ドライパウダー吸入器） - コンビネーション吸入器の用途別セグメント - 世界のコンビネーション吸入器市場規模：用途別分析（喘息、慢性閉塞性肺疾患、その他） - 世界のコンビネーション吸入器市場規模予測（2018年-2029年） - コンビネーション吸入器の平均価格推移（2018年-2029年） - 前提条件と制限事項 ・メーカー別競争状況 - メーカー別市場シェア - 世界の主要メーカー、業界ランキング分析 - メーカー別平均価格 - コンビネーション吸入器市場の競争状況およびトレンド ・コンビネーション吸入器の地域別市場規模 - 北米のコンビネーション吸入器市場規模（2018年-2029年） - アメリカのコンビネーション吸入器市場規模（2018年-2029年） - ヨーロッパのコンビネーション吸入器市場規模（2018年-2029年） - アジア太平洋のコンビネーション吸入器市場規模（2018年-2029年） - 中国のコンビネーション吸入器市場規模（2018年-2029年） - 日本のコンビネーション吸入器市場規模（2018年-2029年） - 韓国のコンビネーション吸入器市場規模（2018年-2029年） - インドのコンビネーション吸入器市場規模（2018年-2029年） - オーストラリアのコンビネーション吸入器市場規模（2018年-2029年） - 中南米のコンビネーション吸入器市場規模（2018年-2029年） - 中東・アフリカのコンビネーション吸入器市場規模（2018年-2029年） ・タイプ別セグメント：加圧定量吸入器、ドライパウダー吸入器 - 世界のコンビネーション吸入器のタイプ別販売量（2018年-2023年） - 世界のコンビネーション吸入器のタイプ別売上（2018年-2023年） - 世界のコンビネーション吸入器のタイプ別価格 ・用途別セグメント：喘息、慢性閉塞性肺疾患、その他 - 世界のコンビネーション吸入器の用途別販売量（2018年-2023年） - 世界のコンビネーション吸入器の用途別売上（2018年-2023年） - 世界のコンビネーション吸入器の用途別価格 ・主要企業のプロファイル：企業情報、事業概要、売上、製品ポートフォリオ、動向 AstraZeneca、GlaxoSmithKline、Zydus Cadila、Cipla、Maya Biotech、Boehringer Ingelheim International GmbH、Novartis AG ・産業チェーンと販売チャネルの分析 - コンビネーション吸入器産業チェーン分析 - コンビネーション吸入器の主要原材料 - コンビネーション吸入器の販売チャネル - コンビネーション吸入器のディストリビューター - コンビネーション吸入器の主要顧客 ・コンビネーション吸入器市場ダイナミクス - コンビネーション吸入器の業界動向 - コンビネーション吸入器市場の成長ドライバ、課題、阻害要因 ・調査成果および結論 ・調査方法とデータソース |
Highlights
The global Combination Inhaler market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Netherlands-Ukraine War were considered while estimating market sizes.
North American market for Combination Inhaler is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
Asia-Pacific market for Combination Inhaler is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The key global manufacturers of Combination Inhaler include AstraZeneca, GlaxoSmithKline, Zydus Cadila, Cipla, Maya Biotech, Boehringer Ingelheim International GmbH and Novartis AG, etc. in 2022, the world’s top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Combination Inhaler, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Combination Inhaler.
The Combination Inhaler market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Combination Inhaler market comprehensively. Regional market sizes, concerning products by type, by application and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Combination Inhaler manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by type, by application and by regions.
By Company
AstraZeneca
GlaxoSmithKline
Zydus Cadila
Cipla
Maya Biotech
Boehringer Ingelheim International GmbH
Novartis AG
Segment by Type
Pressurized Metered Dosage Inhalers
Dry-Powder Inhalers
Segment by Application
Asthma
Chronic Obstructive Pulmonary Disease
Others
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Combination Inhaler manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Combination Inhaler in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the key companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
1 Combination Inhaler Market Overview
1.1 Product Overview and Scope of Combination Inhaler
1.2 Combination Inhaler Segment by Type
1.2.1 Global Combination Inhaler Market Value Comparison by Type (2023-2029)
1.2.2 Pressurized Metered Dosage Inhalers
1.2.3 Dry-Powder Inhalers
1.3 Combination Inhaler Segment by Application
1.3.1 Global Combination Inhaler Market Value by Application: (2023-2029)
1.3.2 Asthma
1.3.3 Chronic Obstructive Pulmonary Disease
1.3.4 Others
1.4 Global Combination Inhaler Market Size Estimates and Forecasts
1.4.1 Global Combination Inhaler Revenue 2018-2029
1.4.2 Global Combination Inhaler Sales 2018-2029
1.4.3 Global Combination Inhaler Market Average Price (2018-2029)
1.5 Assumptions and Limitations
2 Combination Inhaler Market Competition by Manufacturers
2.1 Global Combination Inhaler Sales Market Share by Manufacturers (2018-2023)
2.2 Global Combination Inhaler Revenue Market Share by Manufacturers (2018-2023)
2.3 Global Combination Inhaler Average Price by Manufacturers (2018-2023)
2.4 Global Combination Inhaler Industry Ranking 2021 VS 2022 VS 2023
2.5 Global Key Manufacturers of Combination Inhaler, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Combination Inhaler, Product Type & Application
2.7 Combination Inhaler Market Competitive Situation and Trends
2.7.1 Combination Inhaler Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Combination Inhaler Players Market Share by Revenue
2.7.3 Global Combination Inhaler Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Combination Inhaler Retrospective Market Scenario by Region
3.1 Global Combination Inhaler Market Size by Region: 2018 Versus 2022 Versus 2029
3.2 Global Combination Inhaler Global Combination Inhaler Sales by Region: 2018-2029
3.2.1 Global Combination Inhaler Sales by Region: 2018-2023
3.2.2 Global Combination Inhaler Sales by Region: 2024-2029
3.3 Global Combination Inhaler Global Combination Inhaler Revenue by Region: 2018-2029
3.3.1 Global Combination Inhaler Revenue by Region: 2018-2023
3.3.2 Global Combination Inhaler Revenue by Region: 2024-2029
3.4 North America Combination Inhaler Market Facts & Figures by Country
3.4.1 North America Combination Inhaler Market Size by Country: 2018 VS 2022 VS 2029
3.4.2 North America Combination Inhaler Sales by Country (2018-2029)
3.4.3 North America Combination Inhaler Revenue by Country (2018-2029)
3.4.4 United States
3.4.5 Canada
3.5 Europe Combination Inhaler Market Facts & Figures by Country
3.5.1 Europe Combination Inhaler Market Size by Country: 2018 VS 2022 VS 2029
3.5.2 Europe Combination Inhaler Sales by Country (2018-2029)
3.5.3 Europe Combination Inhaler Revenue by Country (2018-2029)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Combination Inhaler Market Facts & Figures by Country
3.6.1 Asia Pacific Combination Inhaler Market Size by Country: 2018 VS 2022 VS 2029
3.6.2 Asia Pacific Combination Inhaler Sales by Country (2018-2029)
3.6.3 Asia Pacific Combination Inhaler Revenue by Country (2018-2029)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Combination Inhaler Market Facts & Figures by Country
3.7.1 Latin America Combination Inhaler Market Size by Country: 2018 VS 2022 VS 2029
3.7.2 Latin America Combination Inhaler Sales by Country (2018-2029)
3.7.3 Latin America Combination Inhaler Revenue by Country (2018-2029)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Combination Inhaler Market Facts & Figures by Country
3.8.1 Middle East and Africa Combination Inhaler Market Size by Country: 2018 VS 2022 VS 2029
3.8.2 Middle East and Africa Combination Inhaler Sales by Country (2018-2029)
3.8.3 Middle East and Africa Combination Inhaler Revenue by Country (2018-2029)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Combination Inhaler Sales by Type (2018-2029)
4.1.1 Global Combination Inhaler Sales by Type (2018-2023)
4.1.2 Global Combination Inhaler Sales by Type (2024-2029)
4.1.3 Global Combination Inhaler Sales Market Share by Type (2018-2029)
4.2 Global Combination Inhaler Revenue by Type (2018-2029)
4.2.1 Global Combination Inhaler Revenue by Type (2018-2023)
4.2.2 Global Combination Inhaler Revenue by Type (2024-2029)
4.2.3 Global Combination Inhaler Revenue Market Share by Type (2018-2029)
4.3 Global Combination Inhaler Price by Type (2018-2029)
5 Segment by Application
5.1 Global Combination Inhaler Sales by Application (2018-2029)
5.1.1 Global Combination Inhaler Sales by Application (2018-2023)
5.1.2 Global Combination Inhaler Sales by Application (2024-2029)
5.1.3 Global Combination Inhaler Sales Market Share by Application (2018-2029)
5.2 Global Combination Inhaler Revenue by Application (2018-2029)
5.2.1 Global Combination Inhaler Revenue by Application (2018-2023)
5.2.2 Global Combination Inhaler Revenue by Application (2024-2029)
5.2.3 Global Combination Inhaler Revenue Market Share by Application (2018-2029)
5.3 Global Combination Inhaler Price by Application (2018-2029)
6 Key Companies Profiled
6.1 AstraZeneca
6.1.1 AstraZeneca Corporation Information
6.1.2 AstraZeneca Description and Business Overview
6.1.3 AstraZeneca Combination Inhaler Sales, Revenue and Gross Margin (2018-2023)
6.1.4 AstraZeneca Combination Inhaler Product Portfolio
6.1.5 AstraZeneca Recent Developments/Updates
6.2 GlaxoSmithKline
6.2.1 GlaxoSmithKline Corporation Information
6.2.2 GlaxoSmithKline Description and Business Overview
6.2.3 GlaxoSmithKline Combination Inhaler Sales, Revenue and Gross Margin (2018-2023)
6.2.4 GlaxoSmithKline Combination Inhaler Product Portfolio
6.2.5 GlaxoSmithKline Recent Developments/Updates
6.3 Zydus Cadila
6.3.1 Zydus Cadila Corporation Information
6.3.2 Zydus Cadila Description and Business Overview
6.3.3 Zydus Cadila Combination Inhaler Sales, Revenue and Gross Margin (2018-2023)
6.3.4 Zydus Cadila Combination Inhaler Product Portfolio
6.3.5 Zydus Cadila Recent Developments/Updates
6.4 Cipla
6.4.1 Cipla Corporation Information
6.4.2 Cipla Description and Business Overview
6.4.3 Cipla Combination Inhaler Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Cipla Combination Inhaler Product Portfolio
6.4.5 Cipla Recent Developments/Updates
6.5 Maya Biotech
6.5.1 Maya Biotech Corporation Information
6.5.2 Maya Biotech Description and Business Overview
6.5.3 Maya Biotech Combination Inhaler Sales, Revenue and Gross Margin (2018-2023)
6.5.4 Maya Biotech Combination Inhaler Product Portfolio
6.5.5 Maya Biotech Recent Developments/Updates
6.6 Boehringer Ingelheim International GmbH
6.6.1 Boehringer Ingelheim International GmbH Corporation Information
6.6.2 Boehringer Ingelheim International GmbH Description and Business Overview
6.6.3 Boehringer Ingelheim International GmbH Combination Inhaler Sales, Revenue and Gross Margin (2018-2023)
6.6.4 Boehringer Ingelheim International GmbH Combination Inhaler Product Portfolio
6.6.5 Boehringer Ingelheim International GmbH Recent Developments/Updates
6.7 Novartis AG
6.6.1 Novartis AG Corporation Information
6.6.2 Novartis AG Description and Business Overview
6.6.3 Novartis AG Combination Inhaler Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Novartis AG Combination Inhaler Product Portfolio
6.7.5 Novartis AG Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Combination Inhaler Industry Chain Analysis
7.2 Combination Inhaler Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Combination Inhaler Production Mode & Process
7.4 Combination Inhaler Sales and Marketing
7.4.1 Combination Inhaler Sales Channels
7.4.2 Combination Inhaler Distributors
7.5 Combination Inhaler Customers
8 Combination Inhaler Market Dynamics
8.1 Combination Inhaler Industry Trends
8.2 Combination Inhaler Market Drivers
8.3 Combination Inhaler Market Challenges
8.4 Combination Inhaler Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
